These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 13762554)

  • 41. [Optimal conditions in preparation and application of vaccines from complete antigens. II. Immunogenic properties of vaccines].
    POTAPCHIK IuA
    Zh Mikrobiol Epidemiol Immunobiol; 1956 Aug; 27(8):60-6. PubMed ID: 13393658
    [No Abstract]   [Full Text] [Related]  

  • 42. [The spectrum of antibodies in equine and bovine gamma-globulin].
    Trutnev BD; Sekunova AN
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Apr; 46(4):41-3. PubMed ID: 4182940
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effect of environmental high temperature on immunological reactivity in animals].
    AKHNAZAROVA VD
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Jul; 29(7):109. PubMed ID: 13582149
    [No Abstract]   [Full Text] [Related]  

  • 44. [Studies on immunological changes in human subjects vaccinated with IEM Gamaleya chemical combined depot polyvaccine with special reference to dysenterial antigens].
    DEVOINO LV
    Zh Mikrobiol Epidemiol Immunobiol; 1959 Jul; 30():10-4. PubMed ID: 13816299
    [No Abstract]   [Full Text] [Related]  

  • 45. [Changes in the antigenic composition of parenchymatous organs in white mice and young cats infected by dysenterial pathogens].
    BONDARENKO NK; GORCHAKOVA IuP; ZHURAVLEVA ED
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Jun; 31():43-6. PubMed ID: 13802459
    [No Abstract]   [Full Text] [Related]  

  • 46. ON THE ESSENTIAL NATURE OF THE HEMATOPOIETIC FUNCTION OF BONE MARROW. 15. CAUSATIVE TREATMENT OF INFECTIOUS DISEASES FROM THE STANDPOINT OF THE HEMATOPOIETIC PHASES OF THE BONE MARROW AND THE FIELDS OF BLOOD DEFENSE REACTION.
    SAITO A
    Tohoku J Exp Med; 1963 Aug; 80():268-87. PubMed ID: 14067254
    [No Abstract]   [Full Text] [Related]  

  • 47. [Antibody production in infectious diseases].
    Konno J
    Rinsho Byori; 1968 Sep; 16(9):688-95. PubMed ID: 4179643
    [No Abstract]   [Full Text] [Related]  

  • 48. [FURTHER STUDIES ON THE EFFECT OF BACILLARY DYSENTERY ON THE ORGAN OF HEARING].
    BYSTRZANOWSKA T; OSUCH T; POPLAWSKI B; WOJNAROWSKA W
    Otolaryngol Pol; 1964; 18():83-8. PubMed ID: 14202958
    [No Abstract]   [Full Text] [Related]  

  • 49. Intestinal immunoglobulins in shigellosis.
    Reed WP; Williams RC
    Gastroenterology; 1971 Jul; 61(1):35-45. PubMed ID: 4103602
    [No Abstract]   [Full Text] [Related]  

  • 50. THE PATHOGENESIS OF SO-CALLED EKIRI-LIKE SYNDROME AND CONSIDERATION OF TREATMENT OF THE BACILLARY DYSENTERY.
    FUNATSU I
    Tsa Chih Gaoxiong Yi Xue Yuan Tong Xue Hui; 1962 Sep; 61():913-21. PubMed ID: 14067923
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment of chronic bacillary dysentery].
    ANDREEV BI
    Klin Med (Mosk); 1953 Jun; 31(6):82-5. PubMed ID: 13085641
    [No Abstract]   [Full Text] [Related]  

  • 52. [The study of the carriers of bacillary dysentery].
    SAVIC A; IVANCEVIC Z
    Vojnosanit Pregl; 1955; 12(7-8):372-7. PubMed ID: 13282234
    [No Abstract]   [Full Text] [Related]  

  • 53. [Recent data on the epidemiology and therapy of bacillary dysentery].
    DEPARIS M
    Rev Prat; 1951 Dec; 1(7):407-14. PubMed ID: 14912774
    [No Abstract]   [Full Text] [Related]  

  • 54. Immune processes in the course of infection with dysentery bacilli. IV. Transfer of immunity by means of fractions isolated from sera of mice immunized with dysentery bacilli.
    Wieczorek Z; Kowalewska D
    Arch Immunol Ther Exp (Warsz); 1980; 28(2):357-65. PubMed ID: 7004396
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Behavior of total proteins, of protein fractions and of serum electrolytes in patients with acute bacillary dysentery].
    KEDROWA S; POZNANSKA H
    Przegl Epidemiol; 1960; 14():355-60. PubMed ID: 13752132
    [No Abstract]   [Full Text] [Related]  

  • 56. [Role of intestinal Protozoa in the clinical course of bacillary dysentery].
    LIAKHOVETSKII MZ
    Klin Med (Mosk); 1952 May; 30(5):58-61. PubMed ID: 14939509
    [No Abstract]   [Full Text] [Related]  

  • 57. [Epidemiologically specific phages in the treatment of bacillary dysentery].
    BRUGEL H
    Dtsch Med Wochenschr; 1950 Dec; 75(51):1731-2. PubMed ID: 14802159
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical aspects of bacillary dysentery].
    KASSUR B; NAREBSKI J
    Przegl Epidemiol; 1960; 14():215-25. PubMed ID: 13751707
    [No Abstract]   [Full Text] [Related]  

  • 59. [Etiology and epidemiology of bacillary dysentery].
    KOSTRZEWSKI J
    Przegl Epidemiol; 1960; 14():193-214. PubMed ID: 13753448
    [No Abstract]   [Full Text] [Related]  

  • 60. [Modified method of obtaining washings of the large intestine for determining coproantibodies and immunoglobulins in the dynamics of acute dysentery].
    Kasimova NB; Shalygina NB; Burkin VS
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Dec; (12):68-71. PubMed ID: 92867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.